Novavax (NASDAQ: NVAX)
Novavax Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Novavax Company Info
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
News & Analysis
How Bad Is This News for Novavax?
Novavax stock fell 20% in one trading session on the news.
This Vaccine Stock Just Dropped by 20%: Should You Buy the Dip?
Let's look beyond this piece of bad news from regulators.
Should You Buy Novavax Stock After This Regulatory Win?
The biotech continues to earn important wins, but is it enough?
Could This Be the Catalyst Novavax Needs to Get Its Stock Rallying Again?
Regulators recently approved an updated COVID shot from Novavax.
Wall Street Predicts That This Stock Could Skyrocket by 65%: Time to Buy?
Don't be too quick to jump on the bandwagon.
Where Will Novavax Be in 5 Years?
Its been a good year so far for the biotech, but how long can it keep the momentum going?
Where Will Novavax Be in 1 Year?
We will know a lot more about the vaccine maker's long-term prospects in 12 months.
Is It Too Late to Buy Novavax Stock?
Shares of the vaccine maker are trading up 230% this year.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.